ARAX Capital Partners

Greenpass is a software-as-a-service (SaaS) platform dedicated to enhancing climate resilience in urban planning and design, fostering the development of livable cities. The company specializes in managing, optimizing, and certifying both individual real estate assets and entire property portfolios to ensure they meet climate resilience standards. By integrating nature-based solutions and green infrastructures into its offerings, Greenpass addresses critical urban challenges such as climate change, urban heat islands, and microclimates. The platform not only promotes environmentally responsible practices but also aligns with environmental, social, and governance (ESG) regulations, enabling stakeholders to optimize their investments while maximizing overall environmental impact.

CALYXHA Biotechnologies GmbH is a biotechnology company based in Vienna, Austria, established in 2019. The company focuses on developing innovative therapies aimed at addressing tissue degeneration, which is a primary factor in various significant human diseases. Through its research and development efforts, CALYXHA seeks to create solutions that could potentially transform treatment options for patients suffering from conditions linked to tissue degeneration.

EveliQure Biotechnologies GmbH, founded in 2012 and headquartered in Vienna, Austria, focuses on developing innovative vaccines to prevent diarrheal diseases caused by Shigella and ETEC bacteria. The company has achieved a significant milestone by creating the first combined vaccine that protects against both bacterial strains, which have traditionally been targeted by separate vaccine efforts. This combined swallow vaccine utilizes a live attenuated strain of Shigella, engineered to provide broad protection against various species and serotypes of the pathogen. EveliQure's vaccine aims to enhance health outcomes for travelers and individuals living in endemic regions, particularly in middle-income countries, where these bacterial infections pose significant health risks.

MoonVision GmbH is a Vienna-based company founded in August 2017 that specializes in harnessing artificial intelligence to analyze visual information for quality control and process optimization. Recognized as the “Startup of the Year” in its inaugural year, MoonVision gained momentum by partnering with major industry players such as Audi and A1. The company has developed proprietary computer vision algorithms that enable the detection of item types and quantities, facilitating automation and optimizing various processes, including machine operation and payment systems. Its advanced inspection system enhances quality assurance by employing AI-based tracking technology, allowing manufacturers to improve their understanding of production processes and ensure reliability through detailed reporting.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Airborne Robotics GmbH, founded in 2005 and headquartered in Klagenfurt am Wörthersee, Austria, specializes in the design and manufacture of flying robots and drones tailored for industrial, agricultural, cinematic, and photographic applications. The company provides a complete package with its drones, such as the AIR6 and AIR8, which includes essential software and flight training, allowing customers to begin operations immediately upon delivery. These drones support a wide range of cameras and sensors, including thermal imaging and environmental analysis tools, making them adaptable for various tasks. Furthermore, Airborne Robotics promotes an open platform for developers, enabling specialists from diverse fields to customize and program their flying robots for specific functions, as the interfaces and software are readily accessible. The company's products are distributed globally, serving a broad customer base.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

AFFiRiS AG is a biotechnology company based in Vienna, Austria, specializing in the development and manufacture of peptide-based vaccines aimed at the therapeutic treatment of chronic diseases with significant unmet medical needs. Founded in 2003, the company focuses on creating tailored vaccines for a range of conditions, including Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension, diabetes, psoriasis, allergies, asthma, and Huntington’s disease, among others. Through its innovative approach, AFFiRiS seeks to address critical health challenges and improve patient outcomes in various therapeutic areas.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

CONDA Crowdinvesting Österreich is an equity crowdfunding platform based in Vienna, Austria, that facilitates corporate investments and financing for startups and small businesses. The platform enables entrepreneurs to raise capital online, providing them with access to a diverse pool of investors. By focusing on various market segments, CONDA allows investors to make scalable and feasible investments, thereby supporting the growth and development of emerging companies. This model not only benefits businesses seeking funding but also empowers individual investors to participate in the financing of innovative ventures.

Panoptes Pharma is a privately held biotechnology company based in Vienna, Austria, specializing in the development of small molecule therapies for severe eye diseases with significant unmet medical needs. The company's lead clinical candidate, PP-001, targets autoimmune uveitis, a major cause of blindness, and also aims to address adenoviral conjunctivitis, for which there is currently no available treatment. With its unique mode of action, PP-001 has the potential to be effective for various other inflammatory and viral conditions. Panoptes is supported by a team of experienced development experts who have a successful history in bringing innovative products to market, focusing on a targeted portfolio of high-performance small molecule treatments to enhance patient care in ophthalmology.

Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.

CONDA Crowdinvesting Österreich is an equity crowdfunding platform based in Vienna, Austria, that facilitates corporate investments and financing for startups and small businesses. The platform enables entrepreneurs to raise capital online, providing them with access to a diverse pool of investors. By focusing on various market segments, CONDA allows investors to make scalable and feasible investments, thereby supporting the growth and development of emerging companies. This model not only benefits businesses seeking funding but also empowers individual investors to participate in the financing of innovative ventures.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Mechatronic Systemtechnik GmbH, founded in 1998 and headquartered in Villach, Austria, specializes in the development and manufacturing of advanced machines for handling thin and warped wafers used in the semiconductor processing industry. The company offers a range of products including integrated OEM tools, stand-alone tools, loaders, wafer sorters, ring removers, end effectors, pre-aligners, mapping systems, inspection plates, and wafer flipping solutions. With additional locations in Dresden, Germany; Penang, Malaysia; and Singapore, Mechatronic Systemtechnik plays a crucial role in automating processes for its clients, enhancing operational efficiency and yield in semiconductor manufacturing. The company operates as a subsidiary of Accuron Technologies Limited.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

EUCODIS Bioscience GmbH is an enzyme engineering company based in Vienna, Austria, with a subsidiary in Germany. Founded in 2007, the company specializes in the manufacture of high-performing enzyme solutions for diverse applications across the biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. Its product portfolio includes lipases, peroxidases, phospholipase D, nitril hydratases, and various other enzymes, such as catalases and dehydrogenases. These enzymes facilitate processes including the stereospecific resolution of chiral alcohols for API synthesis, the production of sensitive esters, and the synthesis of cosmetic emollient esters. EUCODIS Bioscience also provides services in protein and enzyme engineering, bioprocess development, formulation and analysis, and industrial manufacturing, catering to a growing demand for environmentally sustainable production methods.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

SAIL LABS Technology specializes in developing comprehensive systems and tools for open-source intelligence, focusing on actionable insights derived from various multimedia sources such as television, radio, the internet, and social media. The company’s advanced technologies include automatic speech recognition, speaker identification, and named entity and topic detection, enabling effective analysis across multiple languages and regions. Their platform is designed to assist analysts and decision-makers in extracting valuable information from unstructured data, transforming it into actionable intelligence. The product portfolio also features content-based search capabilities, visualization tools such as clustering and trend analysis, and enhanced workflow functionalities, thereby equipping users with the necessary tools to manage and interpret complex data effectively.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Crystalsol is a technology company specializing in the development and manufacturing of innovative photovoltaic modules, primarily focused on building integration applications and consumer products. Founded in 2007 and based in Tallinn, Estonia, with additional operations in Vienna, Austria, Crystalsol utilizes a patented technology that combines high-efficiency single-crystalline materials with cost-effective roll-to-roll production methods. The company’s modules feature a light-absorbing layer made from a unique crystalline semiconductor powder, which consists of abundant and low-cost elements such as copper, zinc, tin, sulfur, and selenium. This technology allows for the creation of flexible photovoltaic films that can be seamlessly integrated into various structures, including building windows, facades, and rooftops. By eliminating the need for vacuum technology and enabling high throughput, Crystalsol's production process minimizes the capital investment typically required for photovoltaic plants, thereby addressing common scalability challenges associated with thin film technologies.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.

Nabriva Therapeutics plc is a biopharmaceutical company focused on developing and commercializing innovative anti-infective agents to address serious infections. The company's lead product candidate, XENLETA, is the first systemic pleuromutilin antibiotic approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia. In addition to XENLETA, Nabriva is developing CONTEPO, a potential first-in-class epoxide antibiotic aimed at treating complicated urinary tract infections, including acute pyelonephritis. The company is also involved in clinical trials for other indications, including pediatric infections and sexually transmitted infections. Founded in 2005 and headquartered in Dublin, Ireland, Nabriva was previously known as Nabriva Therapeutics Forschungs GmbH before rebranding in 2007.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

EUCODIS Bioscience GmbH is an enzyme engineering company based in Vienna, Austria, with a subsidiary in Germany. Founded in 2007, the company specializes in the manufacture of high-performing enzyme solutions for diverse applications across the biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. Its product portfolio includes lipases, peroxidases, phospholipase D, nitril hydratases, and various other enzymes, such as catalases and dehydrogenases. These enzymes facilitate processes including the stereospecific resolution of chiral alcohols for API synthesis, the production of sensitive esters, and the synthesis of cosmetic emollient esters. EUCODIS Bioscience also provides services in protein and enzyme engineering, bioprocess development, formulation and analysis, and industrial manufacturing, catering to a growing demand for environmentally sustainable production methods.

Mechatronic Systemtechnik GmbH, founded in 1998 and headquartered in Villach, Austria, specializes in the development and manufacturing of advanced machines for handling thin and warped wafers used in the semiconductor processing industry. The company offers a range of products including integrated OEM tools, stand-alone tools, loaders, wafer sorters, ring removers, end effectors, pre-aligners, mapping systems, inspection plates, and wafer flipping solutions. With additional locations in Dresden, Germany; Penang, Malaysia; and Singapore, Mechatronic Systemtechnik plays a crucial role in automating processes for its clients, enhancing operational efficiency and yield in semiconductor manufacturing. The company operates as a subsidiary of Accuron Technologies Limited.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.

Biocrates Life Sciences AG is a biotechnology company based in Innsbruck, Austria, specializing in targeted metabolic phenotyping solutions. Founded in 2002, the company develops and markets mass-spectrometry based kits and services that facilitate the analysis of endogenous metabolites. These tools are essential for discovering and validating biomarkers associated with complex multifactorial diseases, including cancer and neurodegenerative disorders. Biocrates provides a comprehensive metabolomics platform that integrates automated sample preparation workflows with advanced mass-spectrometric techniques, enabling rapid and reliable identification of hundreds of metabolites. Their products and services cater to a wide range of research areas, such as cardiovascular health, diabetes, endocrinology, pharmacology, and more. Biocrates Life Sciences distributes its solutions through authorized partners across various regions, including the Middle East, Europe, and parts of Asia.

Identec Solutions AG specializes in developing advanced wireless sensor network solutions that integrate radio frequency identification (RFID), real-time location systems, and wireless sensing technologies. Based in Lustenau, Austria, with additional offices in the United States, Germany, Norway, and Australia, the company offers a comprehensive ecosystem, including its SensorSMART Platform, which features low-power, long-range sensors and associated infrastructure such as handheld and fixed readers. Its software solutions, including WATCHERSERIES for workforce monitoring and the Container Terminal Automation System for real-time management of logistics, cater to various industries, including automotive, oil and gas, and transportation. Founded in 1997, Identec Solutions has established itself as a leader in the RFID sector, particularly through innovations like its Intelligent Long Range® technology. The company also provides applications for asset tracking, personnel safety, and environmental monitoring, thereby enhancing operational efficiency and safety in challenging environments.